drugset / Trial / NCT02284048

Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina

NCT02284048

RandomizedParallel-groupSingle-blindTreatment

Summary

This study is undertaken to determine if ticagrelor augments adenosine-induced coronary flow reserve (CFR), ameliorates clinical symptomatology and exercise tolerance in patients with MVA

Timeline

Start
2014-11
Primary completion
2016-11
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ticagrelor Small molecule 90 mg